Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Pharma And BioTech News Podcasts

show episodes
 
Artwork

1
The Top Line

Fierce Life Sciences

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
  continue reading
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork

1
BioBiz Buzz

https://biobizbuzz.com/

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork
 
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
  continue reading
 
Artwork

1
Life Science Today

Noah Goodson, PhD

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
  continue reading
 
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
  continue reading
 
Artwork
 
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
  continue reading
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
  continue reading
 
Loading …
show series
 
This Week in Review covers 5 episodes from October 27 to October 31, featuring major developments in the pharmaceutical and biotech industries. Episodes included: 1. Pharma Shifts: Dual-Action Obesity Drugs & Regulatory Waves 2. Navigating Pharma's New Frontiers: Breakthroughs and Challenges 3. Gene Therapy Challenges and Regulatory Shifts: Industr…
  continue reading
 
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the impact of the US Food and Drug Administration announcement that a comparative efficacy study is no longer a prerequisite for biosimilar approval (:35), as well as the upcoming guidance stating the interchangeability switching study r…
  continue reading
 
Welcome to the Fierce Biotech Graveyard, our annual ritual remembering the biotechs we lost in 2025 and those on the brink. In this episode, Fierce Biotech’s Darren Incorvaia and Gabrielle Masson came together to chat about themes from this year’s graveyard, including a cell therapy mausoleum, some mad science, and Darren’s incredibly dated referen…
  continue reading
 
What if we could train AI to understand how stem cells become any cell type in the human body? In this episode of the In Vivo Podcast, host David Wild sits down with Micha Breakstone (CEO & Co-founder) and Samantha Dale Strasser (VP of Strategy) from Somite.AI to explore how their company is using foundation models to revolutionize cell therapy dev…
  continue reading
 
Today, I’m joined by Héctor García Martín, a Staff Scientist at Lawrence Berkeley National Laboratory. A pioneer in metabolic engineering and computational biology, Héctor has spent over a decade decoding microbial systems, everything from termite guts to genome-scale flux models, to unlock sustainable biomanufacturing. Now, he’s leading the charge…
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's focus is on a series of significant advancements that are poised to reshape the landscape of drug development, regulatory standards, and patient care.Eli Lilly has made remarkable strides with its dual-action …
  continue reading
 
스톤브릿지벤쳐스의 김현기 상무는 Scrip과의 인터뷰에서 벤처캐피탈의 국내 바이오 투심 회복을 제약하는 요인과 투자 고려사항, 전략 등을 이야기했습니다. https://insights.citeline.com/scrip/leadership/interviews/a-vc-perspective-on-korean-bioventures-new-catalysts-needed-to-jumpstart-activity-Z7IXGZWZVVGKFDPNOWNJJPMWLQ/Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini…
  continue reading
 
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce a significant milestone — a strategic Contract Development and Manufacturing Organization agreement with Saffron Tech, an agritech leader pioneering advanced and scalable saffron cultivation. The collaboration is focused on developing and commercializing saffron-deri…
  continue reading
 
Has BridgeBio’s business model worked? How are executives at Moderna dealing with the company’s slump? And who will the hosts dress up as for Halloween? We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company’s positive Phase 3 readouts and our colleag…
  continue reading
 
Trust Stamp President Andrew Gowasack joined Steve Darling from Proactive to share that the company has been selected to join Founders Arena, a premier accelerator program that supports emerging innovators in the rapidly growing WealthTech sector.Gowasack noted this milestone comes as Trust Stamp surpasses its 100th financial institution client, a …
  continue reading
 
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to unveil a new strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SKINJECT™, the company’s investigational doxorubicin-containing dissolvable microneedle array therapy for basal cell carcinoma.The initiative focuses on patients wi…
  continue reading
 
Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to discuss a pivotal quarter for the company, highlighted by strong financial performance, expanding profit margins, and the successful integration of its latest acquisition, Eventdex.For the quarter ended September 30, 2025, Nextech3D.AI reported 20% sequential revenue growth and…
  continue reading
 
Rome Resources Plc (AIM:RMR) CEO Paul Barrett talked with Proactive's Stephen Gunnion about the company’s maiden mineral resource for its Bisie North project in the Democratic Republic of Congo.Barrett said the milestone confirms the existence of a tin-copper mineralisation system across the Kalayi and Mont Agoma prospects. The company has so far d…
  continue reading
 
Tertiary Minerals PLC (AIM:TYM, OTC:TTIRF) managing director Richard Belcher talked with Proactive's Stephen Gunnion about the advancement of the Konkola West copper exploration project, where strategic partner KoBold Metals has committed to Stage 2 of the joint venture.The project, located in a world-class copper terrain adjacent to operating mine…
  continue reading
 
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) managing director Shaun Bunn talked with Proactive's Stephen Gunnion about the company’s successful £7 million capital raise and its plans to accelerate development of the Pitfield project.Bunn said the raise was an important milestone that brings the company’s cash reserves to around £11 million, providing …
  continue reading
 
European Green Transition PLC (AIM:EGT) CFO Jack Kelly talked with Proactive's Stephen Gunnion about the company's exclusive six-month option agreement with RMC for the potential sale of its Pajala Copper Project in northern Sweden.Kelly explained that RMC is aiming to build a pan-European portfolio of copper and gold assets to benefit from the Eur…
  continue reading
 
EnergyPathways PLC (AIM:EPP) CEO Ben Clube joined Stephen Gunnion in the Proactive studio with more about the company’s expanding MESH project, which is designed to offer a diverse range of revenue-generating opportunities, including long-duration energy storage, hydrogen production, graphite manufacturing, as well as gas production and storage.Dur…
  continue reading
 
GLP-1s are transforming the lives of people with diabetes and obesity by improving blood glucose control and promoting substantial weight loss. However, medication adherence is a significant challenge. US-based Vivani Medical, a clinical-stage biopharmaceutical company, is developing miniature implants which are designed to solve this problem. Once…
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're exploring a series of significant developments that underscore the rapid evolution within these industries.Starting with one of the major players, Merck, which has been strategically adjusting its focus i…
  continue reading
 
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, welcomes Mike Exton, PhD, CEO of Lexicon Pharmaceuticals, for a conversation about leveraging gene science to develop innovative medicines for serious chronic conditions. Dr. Exton discusses Lexicon’s growing pipeline, which …
  continue reading
 
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) CEO Marc Bishop Lafleche talked with Proactive's Stephen Gunnion about the company’s record third-quarter performance and updated full-year guidance.The update revealed a 112% increase in portfolio contribution compared to Q2 2025, driven largely by base metals royalties. Lafleche highlighted th…
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a dynamic landscape of scientific breakthroughs, regulatory shifts, and strategic maneuvers reshaping the industry.BioMarin's recent decision to divest from its hemophilia A gene therapy, Roctavia…
  continue reading
 
Trust Stamp Chief Science Officer Dr. Norman Poh joined Steve Darling from Proactive to announce that the company has received a notice of allowance for its Non-Provisional Patent Application No. 18/145,470, titled “Systems and Processes for Multifactor Authentication and Identification.”The newly allowed patent covers proprietary techniques that l…
  continue reading
 
Pinnacle Silver and Gold CEO Robert Archer joined Steve Darling from Proactive to share encouraging results from preliminary metallurgical test work at the company’s high-grade El Potrero gold-silver project in Durango, Mexico. Early testing has demonstrated consistently strong gold recoveries, reaching as high as 96.79% and averaging 95.09%, reinf…
  continue reading
 
Silver Range Resources CEO Mike Power joined Steve Darling to share news that the company’s partner, Walker Lane Resources, has initiated an airborne geophysical survey at the Tule Canyon Property in Esmeralda County, Nevada. Walker Lane holds an option to acquire 100% ownership of the property.Power explained that Precision Geosurveys Inc., based …
  continue reading
 
Nextech3D.AI CEO Evan Gappelberg joined Steve Darling from Proactive to share a major growth update as the company continues to scale its AI-powered event technology solutions. Gappelberg revealed that the company’s Eventdex AI Matchmaking platform has generated $100,000 in year-to-date revenue for 2025, delivering an impressive 95% gross profit ma…
  continue reading
 
Valereum PLC (AQSE:VLRM) CEO Gary Cottle talked with Proactive's Stephen Gunnion about the company’s involvement in the COINGT project — a sovereign-grade infrastructure initiative in Guatemala that’s being described as a new Panama Canal on land.Cottle explained that COINGT is a government-backed infrastructure entity offering an alternative trade…
  continue reading
 
Quadrise PLC (AIM:QED) CEO Peter Borup talked with Proactive's Stephen Gunnion about how the recent delay by the International Maritime Organization (IMO) to finalise its net-zero framework is impacting the global shipping industry and the commercial prospects of Quadrise’s cleaner fuel alternatives, MSAR and BioMSAR.Borup said the delay has introd…
  continue reading
 
Light Science Technologies Holdings PLC (AIM:LST) CEO Simon Deacon talked with Proactive's Stephen Gunnion about the company's latest milestone—a new project supporting Nottingham Trent University (NTU) in developing a smart agriculture research centre.Deacon described the £460,000 contract as a significant opportunity to demonstrate the company's …
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into several significant shifts in the industry, marked by scientific advancements, regulatory changes, and strategic corporate maneuvers.Starting with a major acquisition, Novartis has strategical…
  continue reading
 
374 Water Interim CEO Steve Jones joined Steve Darling from Proactive to discuss his recent appointment as the company’s Interim President and Chief Executive Officer. In his new role, Jones will oversee the next stage of project deployments, the commercialization of 374Water’s supercritical water oxidation (SCWO) technology, and the acceleration o…
  continue reading
 
Hive Digital Technologies Executive Chairman Frank Holmes joined Steve Darling from Proactive to announce a major milestone for the company — surpassing 22 Exahash per second in global Bitcoin-mining capacity, representing an impressive 267% growth year-to-date. Alongside this achievement, HIVE is accelerating the transformation of its Tier-1 data …
  continue reading
 
Century Lithium CEO Bill Willoughby joined Steve Darling from Proactive to announce that the company has begun relocating its Lithium Extraction Facility Demonstration Plant to its Tonopah Airport facility in Nevada. This strategic move is designed to consolidate operations, improve logistical efficiency, reduce costs, and strengthen technical supp…
  continue reading
 
North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to share exciting assay results from the company’s Fran Gold Project in British Columbia, where gold grades ranged from 0.4 to over 2.9 ounces per ton.The assays, conducted by ALS Global in North Vancouver, were derived from four ~5-pound samples collected from alternating s…
  continue reading
 
Nanoviricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share major progress in the company’s antiviral research, announcing that its clinical lead drug NV-387 has demonstrated potent activity against the Measles virus in both cell culture studies and a humanized animal model. Notably, the treatment also protected lung tissue, a crit…
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant shifts and strategies shaping our industry.Novartis’s acquisition of Avidity Biosciences for a staggering $12 billion marks a pivotal moment in the pharmaceutical land…
  continue reading
 
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2025年10月24日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本期聚焦柏林欧洲医学肿瘤学会会议的新成果:Enhertu在早期乳腺癌中的应用;Padcev/Keytruda在膀胱癌领域的突破;Pluvicto的III期试验成功;Trodelvy与Datroway在乳腺癌治疗领域的较量;默克公司为乳腺癌治疗带来新希望。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-EWX3A6U4TBE5NPDYX…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended October 24, 2025. In this episode we focus on the most significant results presented at the European Society for Medical Oncology meeting in Berlin: Enhertu in early-stage breast cancer; Padcev/Keytruda in bladder cancer; Phase III wins for Pluvicto; Trodel…
  continue reading
 
This week in review covers 5 episodes from October 20 to October 24, featuring major developments in pharmaceutical and biotech industries including strategic acquisitions, regulatory updates, and clinical trial results. Episodes included: 1. Pharma Innovations: AI's Impact and Strategic Shifts 2. Strategic Acquisitions and AI Revolutionize Pharma …
  continue reading
 
Tonix Pharmaceuticals Holdings CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce that the first patient has been dosed in the investigator-initiated FOCUS study at Massachusetts General Hospital. The study is focused on adult patients with arginine-vasopressin deficiency (AVP-D)—a rare endocrine disorder formerly known as centra…
  continue reading
 
Gunnison Copper Corp SVP and CFO Craig Hallworth joined Steve Darling from Proactive to share exciting results from the company’s ongoing High-Value-Add Work Program, which is evaluating the commercial potential of limestone located within the planned Gunnison Open Pit mine in southeast Arizona.The assessment has revealed that a substantial portion…
  continue reading
 
Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs explain the reasons for the US Food and Drug Administration’s planned “Simple Reform” of its inspection group, including the move away from specialized teams (:44). They also consider industry’s current thinking …
  continue reading
 
This week's episode of "The Top Line" features a discussion about what’s working now in biotech and what isn't. Recorded Oct. 7 at Fierce Biotech Week, this panel featuring leaders from past Fierce 15 winners digs into timelines, partnerships, what's hype, what's signal and how teams are pressure-testing their models in today's market. You'll hear …
  continue reading
 
Vaultz Capital PLC (AQSE:V3TC, OTCQB:VZTCF) CEO Eric Benz talked with Proactive's Stephen Gunnion about the company's admission to trading on the OTCQB Venture Market in the United States.Benz said joining the OTCQB was an important milestone for Vaultz Capital as it enables access to a wider investor base and deeper liquidity. “Being live with OTC…
  continue reading
 
Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris, a methylotrophic yeast that’s revolutionizing pharmaceutical protein production and beyond. From industrial enzymes to biomaterials, food, feed, and diagnostics, Pichia offers a reliable, scalable, a…
  continue reading
 
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into a series of significant events that are shaping the future of drug development and patient care.Starting with Merck KGaA, their decision to close the Active Pharmaceutical Ingredient plan…
  continue reading
 
Can Trump take credit for North Carolina's booming biopharma industry? Which drugs could get a shortcut to the market? And who wore a tuxedo to the STAT Summit? We discuss all that and more in the latest episode of "The Readout LOUD." Elaine is out this week, so Adam and Allison dive into the latest news in the life science industry together, inclu…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play